Magazine Article | September 1, 2020

Building A Biotech: The Third Key Ingredient Beyond Innovation & Funding

Source: Life Science Leader

By Jim Scibetta

During my professional journey I’ve held leadership positions in high-pressured, capital markets-dependent biotech organizations across a wide range of disciplines spanning research, development, manufacturing, commercialization, and all general and administrative functions. Based on my experience, I would argue that if biotech organizations, at the R&D stage in particular, cannot successfully manage their communications practices, they are much more likely to fail regardless of the merits of their innovative technology or ability to secure funding. The highest level of cross-functional communication is the most vital lifeblood in steering a company from discovery to clinical stage.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: